5-[3-[(2-amino-4-pyridinyl)oxy]phenyl]-N-(3-methylphenyl)-1,3,4-oxadiazol-2-amine;5-[3-[6-amino-2-(2,4,6-trimethylphenyl)pyrimidin-4-yl]oxyphenyl]-N-(3-methylphenyl)-1,3,4-oxadiazol-2-amine;methane;5-[3-(7-methoxyquinolin-4-yl)oxyphenyl]-N-(3-methylphenyl)-1,3,4-oxadiazol-2-amine;4-[3-[5-(3-methylanilino)-1,3,4-oxadiazol-2-yl]phenoxy]pyridine-3-sulfonamide;6-[3-[5-(3-methylanilino)-1,3,4-oxadiazol-2-yl]phenoxy]pyrimidine-2,4-diamine;N-(3-methylphenyl)-5-(3-pyridin-4-yloxyphenyl)-1,3,4-oxadiazol-2-amine;N-(3-methylphenyl)-5-(3-quinolin-4-yloxyphenyl)-1,3,4-oxadiazol-2-amine;N-(3-methylphenyl)-5-[3-[[3-(trifluoromethyl)-4-pyridinyl]oxy]phenyl]-1,3,4-oxadiazol-2-amine

C178H150F3N39O19S — CID 160811999

About 5-[3-[(2-amino-4-pyridinyl)oxy]phenyl]-N-(3-methylphenyl)-1,3,4-oxadiazol-2-amine;5-[3-[6-amino-2-(2,4,6-trimethylphenyl)pyrimidin-4-yl]oxyphenyl]-N-(3-methylphenyl)-1,3,4-oxadiazol-2-amine;methane;5-[3-(7-methoxyquinolin-4-yl)oxyphenyl]-N-(3-methylphenyl)-1,3,4-oxadiazol-2-amine;4-[3-[5-(3-methylanilino)-1,3,4-oxadiazol-2-yl]phenoxy]pyridine-3-sulfonamide;6-[3-[5-(3-methylanilino)-1,3,4-oxadiazol-2-yl]phenoxy]pyrimidine-2,4-diamine;N-(3-methylphenyl)-5-(3-pyridin-4-yloxyphenyl)-1,3,4-oxadiazol-2-amine;N-(3-methylphenyl)-5-(3-quinolin-4-yloxyphenyl)-1,3,4-oxadiazol-2-amine;N-(3-methylphenyl)-5-[3-[[3-(trifluoromethyl)-4-pyridinyl]oxy]phenyl]-1,3,4-oxadiazol-2-amine

5-[3-[(2-amino-4-pyridinyl)oxy]phenyl]-N-(3-methylphenyl)-1,3,4-oxadiazol-2-amine;5-[3-[6-amino-2-(2,4,6-trimethylphenyl)pyrimidin-4-yl]oxyphenyl]-N-(3-methylphenyl)-1,3,4-oxadiazol-2-amine;methane;5-[3-(7-methoxyquinolin-4-yl)oxyphenyl]-N-(3-methylphenyl)-1,3,4-oxadiazol-2-amine;4-[3-[5-(3-methylanilino)-1,3,4-oxadiazol-2-yl]phenoxy]pyridine-3-sulfonamide;6-[3-[5-(3-methylanilino)-1,3,4-oxadiazol-2-yl]phenoxy]pyrimidine-2,4-diamine;N-(3-methylphenyl)-5-(3-pyridin-4-yloxyphenyl)-1,3,4-oxadiazol-2-amine;N-(3-methylphenyl)-5-(3-quinolin-4-yloxyphenyl)-1,3,4-oxadiazol-2-amine;N-(3-methylphenyl)-5-[3-[[3-(trifluoromethyl)-4-pyridinyl]oxy]phenyl]-1,3,4-oxadiazol-2-amine (PubChem CID 160811999) has the molecular formula C178H150F3N39O19S and a molecular weight of 3228.47 g/mol. Its IUPAC name is 5-[3-[(2-amino-4-pyridinyl)oxy]phenyl]-N-(3-methylphenyl)-1,3,4-oxadiazol-2-amine;5-[3-[6-amino-2-(2,4,6-trimethylphenyl)pyrimidin-4-yl]oxyphenyl]-N-(3-methylphenyl)-1,3,4-oxadiazol-2-amine;methane;5-[3-(7-methoxyquinolin-4-yl)oxyphenyl]-N-(3-methylphenyl)-1,3,4-oxadiazol-2-amine;4-[3-[5-(3-methylanilino)-1,3,4-oxadiazol-2-yl]phenoxy]pyridine-3-sulfonamide;6-[3-[5-(3-methylanilino)-1,3,4-oxadiazol-2-yl]phenoxy]pyrimidine-2,4-diamine;N-(3-methylphenyl)-5-(3-pyridin-4-yloxyphenyl)-1,3,4-oxadiazol-2-amine;N-(3-methylphenyl)-5-(3-quinolin-4-yloxyphenyl)-1,3,4-oxadiazol-2-amine;N-(3-methylphenyl)-5-[3-[[3-(trifluoromethyl)-4-pyridinyl]oxy]phenyl]-1,3,4-oxadiazol-2-amine.

Molecular Properties

• Compound Name: 5-[3-[(2-amino-4-pyridinyl)oxy]phenyl]-N-(3-methylphenyl)-1,3,4-oxadiazol-2-amine;5-[3-[6-amino-2-(2,4,6-trimethylphenyl)pyrimidin-4-yl]oxyphenyl]-N-(3-methylphenyl)-1,3,4-oxadiazol-2-amine;methane;5-[3-(7-methoxyquinolin-4-yl)oxyphenyl]-N-(3-methylphenyl)-1,3,4-oxadiazol-2-amine;4-[3-[5-(3-methylanilino)-1,3,4-oxadiazol-2-yl]phenoxy]pyridine-3-sulfonamide;6-[3-[5-(3-methylanilino)-1,3,4-oxadiazol-2-yl]phenoxy]pyrimidine-2,4-diamine;N-(3-methylphenyl)-5-(3-pyridin-4-yloxyphenyl)-1,3,4-oxadiazol-2-amine;N-(3-methylphenyl)-5-(3-quinolin-4-yloxyphenyl)-1,3,4-oxadiazol-2-amine;N-(3-methylphenyl)-5-[3-[[3-(trifluoromethyl)-4-pyridinyl]oxy]phenyl]-1,3,4-oxadiazol-2-amine
• PubChem CID: 160811999
• Molecular Formula: C178H150F3N39O19S
• Molecular Weight: 3228.47 g/mol
• Exact Mass: 3226.16
• IUPAC Name: 5-[3-[(2-amino-4-pyridinyl)oxy]phenyl]-N-(3-methylphenyl)-1,3,4-oxadiazol-2-amine;5-[3-[6-amino-2-(2,4,6-trimethylphenyl)pyrimidin-4-yl]oxyphenyl]-N-(3-methylphenyl)-1,3,4-oxadiazol-2-amine;methane;5-[3-(7-methoxyquinolin-4-yl)oxyphenyl]-N-(3-methylphenyl)-1,3,4-oxadiazol-2-amine;4-[3-[5-(3-methylanilino)-1,3,4-oxadiazol-2-yl]phenoxy]pyridine-3-sulfonamide;6-[3-[5-(3-methylanilino)-1,3,4-oxadiazol-2-yl]phenoxy]pyrimidine-2,4-diamine;N-(3-methylphenyl)-5-(3-pyridin-4-yloxyphenyl)-1,3,4-oxadiazol-2-amine;N-(3-methylphenyl)-5-(3-quinolin-4-yloxyphenyl)-1,3,4-oxadiazol-2-amine;N-(3-methylphenyl)-5-[3-[[3-(trifluoromethyl)-4-pyridinyl]oxy]phenyl]-1,3,4-oxadiazol-2-amine
• SMILES: C.COc1ccc2c(Oc3cccc(-c4nnc(Nc5cccc(C)c5)o4)c3)ccnc2c1.Cc1cccc(Nc2nnc(-c3cccc(Oc4cc(N)nc(-c5c(C)cc(C)cc5C)n4)c3)o2)c1.Cc1cccc(Nc2nnc(-c3cccc(Oc4cc(N)nc(N)n4)c3)o2)c1.Cc1cccc(Nc2nnc(-c3cccc(Oc4ccnc(N)c4)c3)o2)c1.Cc1cccc(Nc2nnc(-c3cccc(Oc4ccnc5ccccc45)c3)o2)c1.Cc1cccc(Nc2nnc(-c3cccc(Oc4ccncc4)c3)o2)c1.Cc1cccc(Nc2nnc(-c3cccc(Oc4ccncc4C(F)(F)F)c3)o2)c1.Cc1cccc(Nc2nnc(-c3cccc(Oc4ccncc4S(N)(=O)=O)c3)o2)c1
• InChI: InChI=1S/C28H26N6O2.C25H20N4O3.C24H18N4O2.C21H15F3N4O2.C20H17N5O4S.C20H17N5O2.C20H16N4O2.C19H17N7O2.CH4/c1-16-7-5-9-21(13-16)30-28-34-33-27(36-28)20-8-6-10-22(14-20)35-24-15-23(29)31-26(32-24)25-18(3)11-17(2)12-19(25)4;1-16-5-3-7-18(13-16)27-25-29-28-24(32-25)17-6-4-8-20(14-17)31-23-11-12-26-22-15-19(30-2)9-10-21(22)23;1-16-6-4-8-18(14-16)26-24-28-27-23(30-24)17-7-5-9-19(15-17)29-22-12-13-25-21-11-3-2-10-20(21)22;1-13-4-2-6-15(10-13)26-20-28-27-19(30-20)14-5-3-7-16(11-14)29-18-8-9-25-12-17(18)21(22,23)24;1-13-4-2-6-15(10-13)23-20-25-24-19(29-20)14-5-3-7-16(11-14)28-17-8-9-22-12-18(17)30(21,26)27;1-13-4-2-6-15(10-13)23-20-25-24-19(27-20)14-5-3-7-16(11-14)26-17-8-9-22-18(21)12-17;1-14-4-2-6-16(12-14)22-20-24-23-19(26-20)15-5-3-7-18(13-15)25-17-8-10-21-11-9-17;1-11-4-2-6-13(8-11)22-19-26-25-17(28-19)12-5-3-7-14(9-12)27-16-10-15(20)23-18(21)24-16;/h5-15H,1-4H3,(H,30,34)(H2,29,31,32);3-15H,1-2H3,(H,27,29);2-15H,1H3,(H,26,28);2-12H,1H3,(H,26,28);2-12H,1H3,(H,23,25)(H2,21,26,27);2-12H,1H3,(H2,21,22)(H,23,25);2-13H,1H3,(H,22,24);2-10H,1H3,(H,22,26)(H4,20,21,23,24);1H4
• InChIKey: SEKKPPXFZBMRAA-UHFFFAOYSA-N
• XLogP: 42.14
• TPSA: 783.81 Ų
• H-Bond Donors: 13
• H-Bond Acceptors: 57
• Rotatable Bonds: 43
• Heavy Atoms: 240
• Complexity: —

Lipinski Rule of Five

4 violations

Rule	Value
MW ≤ 500	3228.47
LogP ≤ 5	42.14
H-Bond Donors ≤ 5	13
H-Bond Acceptors ≤ 10	57

Frequently Asked Questions

What is the IUPAC name of 5-[3-[(2-amino-4-pyridinyl)oxy]phenyl]-N-(3-methylphenyl)-1,3,4-oxadiazol-2-amine;5-[3-[6-amino-2-(2,4,6-trimethylphenyl)pyrimidin-4-yl]oxyphenyl]-N-(3-methylphenyl)-1,3,4-oxadiazol-2-amine;methane;5-[3-(7-methoxyquinolin-4-yl)oxyphenyl]-N-(3-methylphenyl)-1,3,4-oxadiazol-2-amine;4-[3-[5-(3-methylanilino)-1,3,4-oxadiazol-2-yl]phenoxy]pyridine-3-sulfonamide;6-[3-[5-(3-methylanilino)-1,3,4-oxadiazol-2-yl]phenoxy]pyrimidine-2,4-diamine;N-(3-methylphenyl)-5-(3-pyridin-4-yloxyphenyl)-1,3,4-oxadiazol-2-amine;N-(3-methylphenyl)-5-(3-quinolin-4-yloxyphenyl)-1,3,4-oxadiazol-2-amine;N-(3-methylphenyl)-5-[3-[[3-(trifluoromethyl)-4-pyridinyl]oxy]phenyl]-1,3,4-oxadiazol-2-amine?

The IUPAC name of 5-[3-[(2-amino-4-pyridinyl)oxy]phenyl]-N-(3-methylphenyl)-1,3,4-oxadiazol-2-amine;5-[3-[6-amino-2-(2,4,6-trimethylphenyl)pyrimidin-4-yl]oxyphenyl]-N-(3-methylphenyl)-1,3,4-oxadiazol-2-amine;methane;5-[3-(7-methoxyquinolin-4-yl)oxyphenyl]-N-(3-methylphenyl)-1,3,4-oxadiazol-2-amine;4-[3-[5-(3-methylanilino)-1,3,4-oxadiazol-2-yl]phenoxy]pyridine-3-sulfonamide;6-[3-[5-(3-methylanilino)-1,3,4-oxadiazol-2-yl]phenoxy]pyrimidine-2,4-diamine;N-(3-methylphenyl)-5-(3-pyridin-4-yloxyphenyl)-1,3,4-oxadiazol-2-amine;N-(3-methylphenyl)-5-(3-quinolin-4-yloxyphenyl)-1,3,4-oxadiazol-2-amine;N-(3-methylphenyl)-5-[3-[[3-(trifluoromethyl)-4-pyridinyl]oxy]phenyl]-1,3,4-oxadiazol-2-amine (CID 160811999) is 5-[3-[(2-amino-4-pyridinyl)oxy]phenyl]-N-(3-methylphenyl)-1,3,4-oxadiazol-2-amine;5-[3-[6-amino-2-(2,4,6-trimethylphenyl)pyrimidin-4-yl]oxyphenyl]-N-(3-methylphenyl)-1,3,4-oxadiazol-2-amine;methane;5-[3-(7-methoxyquinolin-4-yl)oxyphenyl]-N-(3-methylphenyl)-1,3,4-oxadiazol-2-amine;4-[3-[5-(3-methylanilino)-1,3,4-oxadiazol-2-yl]phenoxy]pyridine-3-sulfonamide;6-[3-[5-(3-methylanilino)-1,3,4-oxadiazol-2-yl]phenoxy]pyrimidine-2,4-diamine;N-(3-methylphenyl)-5-(3-pyridin-4-yloxyphenyl)-1,3,4-oxadiazol-2-amine;N-(3-methylphenyl)-5-(3-quinolin-4-yloxyphenyl)-1,3,4-oxadiazol-2-amine;N-(3-methylphenyl)-5-[3-[[3-(trifluoromethyl)-4-pyridinyl]oxy]phenyl]-1,3,4-oxadiazol-2-amine.

What is the SMILES notation for 5-[3-[(2-amino-4-pyridinyl)oxy]phenyl]-N-(3-methylphenyl)-1,3,4-oxadiazol-2-amine;5-[3-[6-amino-2-(2,4,6-trimethylphenyl)pyrimidin-4-yl]oxyphenyl]-N-(3-methylphenyl)-1,3,4-oxadiazol-2-amine;methane;5-[3-(7-methoxyquinolin-4-yl)oxyphenyl]-N-(3-methylphenyl)-1,3,4-oxadiazol-2-amine;4-[3-[5-(3-methylanilino)-1,3,4-oxadiazol-2-yl]phenoxy]pyridine-3-sulfonamide;6-[3-[5-(3-methylanilino)-1,3,4-oxadiazol-2-yl]phenoxy]pyrimidine-2,4-diamine;N-(3-methylphenyl)-5-(3-pyridin-4-yloxyphenyl)-1,3,4-oxadiazol-2-amine;N-(3-methylphenyl)-5-(3-quinolin-4-yloxyphenyl)-1,3,4-oxadiazol-2-amine;N-(3-methylphenyl)-5-[3-[[3-(trifluoromethyl)-4-pyridinyl]oxy]phenyl]-1,3,4-oxadiazol-2-amine?

The canonical SMILES for 5-[3-[(2-amino-4-pyridinyl)oxy]phenyl]-N-(3-methylphenyl)-1,3,4-oxadiazol-2-amine;5-[3-[6-amino-2-(2,4,6-trimethylphenyl)pyrimidin-4-yl]oxyphenyl]-N-(3-methylphenyl)-1,3,4-oxadiazol-2-amine;methane;5-[3-(7-methoxyquinolin-4-yl)oxyphenyl]-N-(3-methylphenyl)-1,3,4-oxadiazol-2-amine;4-[3-[5-(3-methylanilino)-1,3,4-oxadiazol-2-yl]phenoxy]pyridine-3-sulfonamide;6-[3-[5-(3-methylanilino)-1,3,4-oxadiazol-2-yl]phenoxy]pyrimidine-2,4-diamine;N-(3-methylphenyl)-5-(3-pyridin-4-yloxyphenyl)-1,3,4-oxadiazol-2-amine;N-(3-methylphenyl)-5-(3-quinolin-4-yloxyphenyl)-1,3,4-oxadiazol-2-amine;N-(3-methylphenyl)-5-[3-[[3-(trifluoromethyl)-4-pyridinyl]oxy]phenyl]-1,3,4-oxadiazol-2-amine is C.COc1ccc2c(Oc3cccc(-c4nnc(Nc5cccc(C)c5)o4)c3)ccnc2c1.Cc1cccc(Nc2nnc(-c3cccc(Oc4cc(N)nc(-c5c(C)cc(C)cc5C)n4)c3)o2)c1.Cc1cccc(Nc2nnc(-c3cccc(Oc4cc(N)nc(N)n4)c3)o2)c1.Cc1cccc(Nc2nnc(-c3cccc(Oc4ccnc(N)c4)c3)o2)c1.Cc1cccc(Nc2nnc(-c3cccc(Oc4ccnc5ccccc45)c3)o2)c1.Cc1cccc(Nc2nnc(-c3cccc(Oc4ccncc4)c3)o2)c1.Cc1cccc(Nc2nnc(-c3cccc(Oc4ccncc4C(F)(F)F)c3)o2)c1.Cc1cccc(Nc2nnc(-c3cccc(Oc4ccncc4S(N)(=O)=O)c3)o2)c1.

What is the InChIKey of 5-[3-[(2-amino-4-pyridinyl)oxy]phenyl]-N-(3-methylphenyl)-1,3,4-oxadiazol-2-amine;5-[3-[6-amino-2-(2,4,6-trimethylphenyl)pyrimidin-4-yl]oxyphenyl]-N-(3-methylphenyl)-1,3,4-oxadiazol-2-amine;methane;5-[3-(7-methoxyquinolin-4-yl)oxyphenyl]-N-(3-methylphenyl)-1,3,4-oxadiazol-2-amine;4-[3-[5-(3-methylanilino)-1,3,4-oxadiazol-2-yl]phenoxy]pyridine-3-sulfonamide;6-[3-[5-(3-methylanilino)-1,3,4-oxadiazol-2-yl]phenoxy]pyrimidine-2,4-diamine;N-(3-methylphenyl)-5-(3-pyridin-4-yloxyphenyl)-1,3,4-oxadiazol-2-amine;N-(3-methylphenyl)-5-(3-quinolin-4-yloxyphenyl)-1,3,4-oxadiazol-2-amine;N-(3-methylphenyl)-5-[3-[[3-(trifluoromethyl)-4-pyridinyl]oxy]phenyl]-1,3,4-oxadiazol-2-amine?

The InChIKey is SEKKPPXFZBMRAA-UHFFFAOYSA-N. The full InChI is InChI=1S/C28H26N6O2.C25H20N4O3.C24H18N4O2.C21H15F3N4O2.C20H17N5O4S.C20H17N5O2.C20H16N4O2.C19H17N7O2.CH4/c1-16-7-5-9-21(13-16)30-28-34-33-27(36-28)20-8-6-10-22(14-20)35-24-15-23(29)31-26(32-24)25-18(3)11-17(2)12-19(25)4;1-16-5-3-7-18(13-16)27-25-29-28-24(32-25)17-6-4-8-20(14-17)31-23-11-12-26-22-15-19(30-2)9-10-21(22)23;1-16-6-4-8-18(14-16)26-24-28-27-23(30-24)17-7-5-9-19(15-17)29-22-12-13-25-21-11-3-2-10-20(21)22;1-13-4-2-6-15(10-13)26-20-28-27-19(30-20)14-5-3-7-16(11-14)29-18-8-9-25-12-17(18)21(22,23)24;1-13-4-2-6-15(10-13)23-20-25-24-19(29-20)14-5-3-7-16(11-14)28-17-8-9-22-12-18(17)30(21,26)27;1-13-4-2-6-15(10-13)23-20-25-24-19(27-20)14-5-3-7-16(11-14)26-17-8-9-22-18(21)12-17;1-14-4-2-6-16(12-14)22-20-24-23-19(26-20)15-5-3-7-18(13-15)25-17-8-10-21-11-9-17;1-11-4-2-6-13(8-11)22-19-26-25-17(28-19)12-5-3-7-14(9-12)27-16-10-15(20)23-18(21)24-16;/h5-15H,1-4H3,(H,30,34)(H2,29,31,32);3-15H,1-2H3,(H,27,29);2-15H,1H3,(H,26,28);2-12H,1H3,(H,26,28);2-12H,1H3,(H,23,25)(H2,21,26,27);2-12H,1H3,(H2,21,22)(H,23,25);2-13H,1H3,(H,22,24);2-10H,1H3,(H,22,26)(H4,20,21,23,24);1H4.

What are the key properties of 5-[3-[(2-amino-4-pyridinyl)oxy]phenyl]-N-(3-methylphenyl)-1,3,4-oxadiazol-2-amine;5-[3-[6-amino-2-(2,4,6-trimethylphenyl)pyrimidin-4-yl]oxyphenyl]-N-(3-methylphenyl)-1,3,4-oxadiazol-2-amine;methane;5-[3-(7-methoxyquinolin-4-yl)oxyphenyl]-N-(3-methylphenyl)-1,3,4-oxadiazol-2-amine;4-[3-[5-(3-methylanilino)-1,3,4-oxadiazol-2-yl]phenoxy]pyridine-3-sulfonamide;6-[3-[5-(3-methylanilino)-1,3,4-oxadiazol-2-yl]phenoxy]pyrimidine-2,4-diamine;N-(3-methylphenyl)-5-(3-pyridin-4-yloxyphenyl)-1,3,4-oxadiazol-2-amine;N-(3-methylphenyl)-5-(3-quinolin-4-yloxyphenyl)-1,3,4-oxadiazol-2-amine;N-(3-methylphenyl)-5-[3-[[3-(trifluoromethyl)-4-pyridinyl]oxy]phenyl]-1,3,4-oxadiazol-2-amine?

5-[3-[(2-amino-4-pyridinyl)oxy]phenyl]-N-(3-methylphenyl)-1,3,4-oxadiazol-2-amine;5-[3-[6-amino-2-(2,4,6-trimethylphenyl)pyrimidin-4-yl]oxyphenyl]-N-(3-methylphenyl)-1,3,4-oxadiazol-2-amine;methane;5-[3-(7-methoxyquinolin-4-yl)oxyphenyl]-N-(3-methylphenyl)-1,3,4-oxadiazol-2-amine;4-[3-[5-(3-methylanilino)-1,3,4-oxadiazol-2-yl]phenoxy]pyridine-3-sulfonamide;6-[3-[5-(3-methylanilino)-1,3,4-oxadiazol-2-yl]phenoxy]pyrimidine-2,4-diamine;N-(3-methylphenyl)-5-(3-pyridin-4-yloxyphenyl)-1,3,4-oxadiazol-2-amine;N-(3-methylphenyl)-5-(3-quinolin-4-yloxyphenyl)-1,3,4-oxadiazol-2-amine;N-(3-methylphenyl)-5-[3-[[3-(trifluoromethyl)-4-pyridinyl]oxy]phenyl]-1,3,4-oxadiazol-2-amine has a molecular weight of 3228.47 g/mol, XLogP of 42.14, 43 rotatable bonds, 13 hydrogen bond donors, and 57 hydrogen bond acceptors.

Where does this data come from?

All data for 5-[3-[(2-amino-4-pyridinyl)oxy]phenyl]-N-(3-methylphenyl)-1,3,4-oxadiazol-2-amine;5-[3-[6-amino-2-(2,4,6-trimethylphenyl)pyrimidin-4-yl]oxyphenyl]-N-(3-methylphenyl)-1,3,4-oxadiazol-2-amine;methane;5-[3-(7-methoxyquinolin-4-yl)oxyphenyl]-N-(3-methylphenyl)-1,3,4-oxadiazol-2-amine;4-[3-[5-(3-methylanilino)-1,3,4-oxadiazol-2-yl]phenoxy]pyridine-3-sulfonamide;6-[3-[5-(3-methylanilino)-1,3,4-oxadiazol-2-yl]phenoxy]pyrimidine-2,4-diamine;N-(3-methylphenyl)-5-(3-pyridin-4-yloxyphenyl)-1,3,4-oxadiazol-2-amine;N-(3-methylphenyl)-5-(3-quinolin-4-yloxyphenyl)-1,3,4-oxadiazol-2-amine;N-(3-methylphenyl)-5-[3-[[3-(trifluoromethyl)-4-pyridinyl]oxy]phenyl]-1,3,4-oxadiazol-2-amine is sourced from PubChem (CID 160811999), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).